|
Xu, Liang; Huang, Cheng-Cheng; Huang, Weiqun et al. (2002) Systemic tumor-targeted gene delivery by anti-transferrin receptor scFv-immunoliposomes. Mol Cancer Ther 1:337-46
|
|
Sherif, Z A; Nakai, S; Pirollo, K F et al. (2001) Downmodulation of bFGF-binding protein expression following restoration of p53 function. Cancer Gene Ther 8:771-82
|
|
Xu, L; Pirollo, K F; Chang, E H (2001) Tumor-targeted p53-gene therapy enhances the efficacy of conventional chemo/radiotherapy. J Control Release 74:115-28
|
|
Xu, L; Tang, W H; Huang, C C et al. (2001) Systemic p53 gene therapy of cancer with immunolipoplexes targeted by anti-transferrin receptor scFv. Mol Med 7:723-34
|
|
Pirollo, K F; Bouker, K B; Chang, E H (2000) Does p53 status influence tumor response to anticancer therapies? Anticancer Drugs 11:419-32
|
|
Xu, L; Pirollo, K F; Tang, W H et al. (1999) Transferrin-liposome-mediated systemic p53 gene therapy in combination with radiation results in regression of human head and neck cancer xenografts. Hum Gene Ther 10:2941-52
|
|
Pirollo, K F; Hao, Z; Rait, A et al. (1997) Evidence supporting a signal transduction pathway leading to the radiation-resistant phenotype in human tumor cells. Biochem Biophys Res Commun 230:196-201
|
|
Xu, L; Pirollo, K F; Chang, E H (1997) Transferrin-liposome-mediated p53 sensitization of squamous cell carcinoma of the head and neck to radiation in vitro. Hum Gene Ther 8:467-75
|
|
Pirollo, K F; Hao, Z; Rait, A et al. (1997) p53 mediated sensitization of squamous cell carcinoma of the head and neck to radiotherapy. Oncogene 14:1735-46
|
|
Srivastava, S; Wang, S; Tong, Y A et al. (1993) Several mutant p53 proteins detected in cancer-prone families with Li-Fraumeni syndrome exhibit transdominant effects on the biochemical properties of the wild-type p53. Oncogene 8:2449-56
|
Showing the most recent 10 out of 16 publications
